- Co-Diagnostics will release Q3 2026 results after market close on November 12, 2026.
Co-Diagnostics (CODX) will report third quarter 2026 results after the market close on Thursday, November 12, 2026, followed by a conference call and webcast at 4:30 p.m. ET. CEO Dwight Egan and EVP of Finance and Accounting Daniel Bohrer will lead the call. The webcast will be available on the company's investor relations site, with a replay posted afterward.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.